These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure. Miyagi Y, Sasayama S, Nakajima H, Fujita M, Asanoi H. J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971 [Abstract] [Full Text] [Related]
29. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A. G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [Abstract] [Full Text] [Related]
30. Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone. Guimond JG, Matuschak GM, Meyers F, Keating D. Chest; 1986 Aug; 90(2):302-4. PubMed ID: 3731911 [Abstract] [Full Text] [Related]
32. [The hemodynamic profile of the response to amrinone treatment in severe heart failure]. Domínguez de Rozas J, García Picart J, Guindo Soldevila J, Altimiras Ruiz J, Binia Mizrahi M, Pastor Ramón E, Bayés de Luna A. Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366 [Abstract] [Full Text] [Related]